Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages.
Sponsor: Imperial College London
A observational or N/A phase clinical study on Antiphospholipid Syndrome, this trial is completed. The trial is conducted by Imperial College London and has accumulated 7 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Sep 2022 [monthly]
Completed
-
Apr 2019 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
▶ Show 2 earlier versions
-
Apr 2018 — Apr 2019 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Sep 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Imperial College London
For direct contact, visit the study record on ClinicalTrials.gov .